Definium Therapeutics Inc. Common Shares vs Fortive Corporation Common Stock — how do they compare? Definium Therapeutics Inc. Common Shares trades at $34.01 (market cap $4.71B), while Fortive Corporation Common Stock trades at $56.51 (market cap $17.07B). The key difference: Fortive Corporation Common Stock is far larger — about 3.6× Definium Therapeutics Inc. Common Shares's market cap, and Fortive Corporation Common Stock pays a 0.5% dividend while Definium Therapeutics Inc. Common Shares pays none. Which is the better fit depends on your goals — on Pluang, investors hold Definium Therapeutics Inc. Common Shares for 0 Days and Fortive Corporation Common Stock for 0 Days on average.
| DFTX | FTV | |
|---|---|---|
Market Cap | $4.71B | $17.07B |
Volume | 1,966,636 | 1,773,097 |
Sector | Health | Technology |
52-Week High | $48.45 | $64.09 |
52-Week Low | $10.68 | $47.80 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $3.67B | $20.21B |
Dividend Yield | — | 0.5% |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Definium Therapeutics develops investigational treatments for psychiatric and neurological disorders. Formerly MindMed, it focuses on clinical-stage therapies based on novel psychoactive compounds.
Read more on DFTX →Fortive provides industrial and healthcare technology solutions. Its products and software support measurement, maintenance, worker safety, instrument sterilization, and clinical workflows.
Read more on FTV →